Global Alopecia Treatment Market, by Disease Type (Androgenic Alopecia, Alopecia Areata, and Others), by Drug Type (Topical Agents, 5 AR Inhibitors, Corticosteroids, and Others), by Gender (Male and Female), by Route of Administration (Oral, Topical, and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 7,325.0 million in 2017, and is projected to exhibit a CAGR of 4.9% over the forecast period (2018–2026).
Increasing product approvals and product launches by market players is expected to augment the market growth
Key players in the market are focused on product launches and product approvals, in order to develop novel products to address critical unmet needs of patients. For instance, in July 2018, Aclaris Therapeutics, Inc. received the U.S. Food and Drug Administration (FDA) grant as the Fast Track designation to Aclaris’ investigational topical Janus Kinase (JAK) 1/3 inhibitor (ATI-502) for the treatment of alopecia areata, including patchy alopecia areata and variants of the disease, alopecia totalis and universalis. Moreover, robust pipeline is expected launch advanced drugs for alopecia in the near future which can boost the market growth. For instance, in June 2018, Almirall, a company based in Spain, published the results of Phase III trial of ALM12845/P-3074 for androgenic alopecia. The company is planning for the regulatory filing of the drug in the E.U. by the end of 2019.
Browse 31 Market Data Tables and 25 Figures spread through 193 Pages and in-depth TOC on ‘Alopecia Treatment Market’- Global Forecast to 2026, by Disease Type (Androgenic Alopecia, Alopecia Areata, and Others), by Drug Type (Topical Agents, 5 AR Inhibitors, Corticosteroids, and Others), by Gender (Male and Female), by Route of Administration (Oral, Topical, and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in the global alopecia treatment market, click the link below:
Furthermore, increasing use of chemotherapy and radiation therapy for treatment of cancer, induces alopecia, which is expected to drive the global alopecia treatment market growth. According to the study published in National Center for Biotechnology Information (NCBI), February 2017, incidence of alopecia associated with chemotherapy drug categories such as topoisomerase inhibitors causes around 60% to 100 % alopecia, Anti microtubule agents caused around 80% alopecia. Key players in the market are focused on adopting strategies such as mergers and acquisitions to enhance their product portfolio. For instance, in 2017, Aclaris Therapeutics, Inc. acquired Confluence Life Sciences, Inc., a company focused on discovery and development of kinase inhibitors to treat autoimmune disorders such as alopecia areata, vitiligo, atopic dermatitis, and others.
Key Takeaways of the Global Alopecia Treatment Market:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.